Apart from ensuring our members do not find themselves in hospitals, the SAMWUMED Cares Wellness Programme and early detection benefit provides members with an opportunity to take ownership of their own health.
Our amazing Programmes includes the following screenings:
- Age: Adults aged 18 yrs and older.
- Screening Test: Blood Pressure.
- 2022: Up to one screening Per beneficiary per year.
- Age: 18 yrs and older.
- Screening Test: Type II diabetes.
- 2022: Up to one screening per beneficiary aged 18 years and older per year.
- Age: From age 20
- Screening Test: Total Blood Cholesterol.
- 2022: Up to one test for all adults at least once from the age of 20 years old and every year for high risk members.
- Age: 18 years and older.
- Screening Test: Papanicolaou (Pap) test, Chlamydia screening.
- 2022: Up to one screening Per beneficiary per year within a 2 year cycle.
- Age: Childbearing age.
- Screening Test: Folic Acid.
- 2022: Up to 1 per month for the first 3 months of pregnancy.
- Age: 50 Yrs and older.
- Screening Test: Faecal occult blood test.
- 2022: Up to one screening Per beneficiary per year.
- Age: Over the age of 45 until the age of 70.
- Screening Test: Mammogram.
- 2022: Up to one screening per female beneficiary every two years over the age of 45 until age of 70 years.
- Age: 45 yrs to 70 yrs.
- Screening Test: Bone Density Test.
- 2022: Up to one Per beneficiary per year.
- Age: All Ages.
- Screening Test: HIV.
- 2022: One test per member per annum.
- Screening Test: Cytology.
- 2022: One test per beneficiary, every three years
- Age: Less than 1 month old.
- Screening Test: TSH screening.
- 2022: Once-off for hyperthyroidism in new-borns.
- Screening Test: Flu vaccine.
- 2022: Up to one vaccination per beneficiary per annum.
- Screening Test: HPV.
- 2022: Up to one test per female beneficiary every five years
- Screening Test: Child Immunisation.
- 2022: As per Immunisations prescribed by the South African Expanded Immunisation Programme.
- Screening Test: Pneumococcal vaccine.
- 2022: Up to one vaccination per beneficiary 65 years and older and for beneficiaries aged 2 to 64 years who are at risk of serious pneumococcal disease per lifetime.
- Age: Females 9 to 14 yrs.
- Screening Test: HVP Vaccine.
- 2022: Up to one vaccination per female beneficiary between age 9 and 14 years per annum. Vaccination includes 2 doses administered over 6 months in the same benefit year.
- Age: 7 yrs to 64 yrs.
- Screening Test: Pertussis (Whooping Cough) Booster.
- 2022: Up to one vaccination per beneficiary between age 7 and 64 are eligible for the booster dose every 10 years.
- Age: 18 years and older.
- Screening Test: Chlamydia Test
- 2022: Up to one test per female beneficiary within a 2-year cycle.
- Age: All beneficiaries.
- Screening Test: Health Risk Assessment
- 2022: Up to one assessment per beneficiary per year.
- Age: New-borns.
- Screening Test: Hearing Test
- 2022: One hearing test per new-born baby administered by an audiologist 2023.
Nappi codes - SMU EPI & Pneumococcal
Nappi codes - SMU EPI
|
NAPPI
|
NAPPI_DESCRIPTION
|
STRENGTH
|
|---|---|---|
|
715858
|
PREVENAR 13 PRE-FILLED SYRINGE 0.5ML
|
28MCG/.5ML
|
|
842443
|
DT VAX 0.5ML SINGLE DOSE
|
|
|
722290
|
MEASBIO MULTI-DOSE VIAL POWDER FOR INJ +
|
|
|
825522
|
ROUVAX SGL DOSE SYR
|
|
|
722017
|
BIVALENT ORAL POLIO MERIEUX 20 DOSE VIAL
|
|
|
714133
|
ROTARIX LIQUID ORAL
|
|
|
710935
|
ROTATEQ 2ML
|
|
|
719637
|
HEXAXIM 0.5ML
|
|
|
872962
|
BCG INTRADERMAL INFANT VIAL POWDER FOR R
|
0.75MG
|
|
565499
|
SYRINGE INTRA 1ML
|
|
Nappi codes - Pneumococcal
|
NAPPI
|
NAPPI_DESCRIPTION
|
STRENGTH
|
|---|---|---|
|
836699
|
IMOVAX PNEUMO 23
|
.025MG/.5ML
|
|
755826
|
PNEUMOVAX 23 SINGLE DOSE VIAL 0.5ML
|
|
|
715858
|
PREVENAR 13 PRE-FILLED SYRINGE 0.5ML
|
28MCG/.5ML
|
